Emerging drugs in metastatic breast cancer: an update


Arslan C., Altundag K., Dizdar O.

EXPERT OPINION ON EMERGING DRUGS, vol.16, no.4, pp.647-667, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 16 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.1517/14728214.2011.640672
  • Journal Name: EXPERT OPINION ON EMERGING DRUGS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.647-667
  • Hacettepe University Affiliated: Yes

Abstract

Introduction: The incidence of breast cancer at an advanced stage has decreased in the modern world due to screening programs and usage of novel chemotherapy agents at an adjuvant setting. Recurrence is the major problem seen in > 50% of breast cancer patients diagnosed at an early stage. Developing new drugs for metastatic breast cancer is a huge and challenging research area.